INTEGRA LIFESCIENCES HOLDINGS CORP Selling, General and Administrative Expense
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Selling, General and Administrative Expense of $172.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP selling, general and administrative expense for the quarter ending 2026-06-30 was $172.44M, a 4.14% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP selling, general and administrative expense for the quarter ending 2026-03-31 was $178.24M, a 1.80% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP selling, general and administrative expense for the quarter ending 2025-12-31 was $169.27M, a 5.18% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP selling, general and administrative expense for the quarter ending 2025-09-30 was $169.05M, a 4.60% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP selling, general and administrative expense for fiscal 2025 was $699.70M, a 2.41% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP selling, general and administrative expense for fiscal 2024 was $716.98M, a 9.19% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP selling, general and administrative expense for fiscal 2023 was $656.64M, a 6.54% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP selling, general and administrative expense for fiscal 2022 was $616.32M, a 3.31% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $172.44M 10-Q · filed 2026-07-29 | $350.67M 10-Q · filed 2026-07-29 | $519.94M derived: sum of 3 quarters · filed 2026-07-29 | $688.98M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $178.24M 10-Q · filed 2026-05-05 | $347.50M derived: sum of 2 quarters · filed 2026-05-05 | $516.55M derived: sum of 3 quarters · filed 2026-05-05 | $696.44M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $169.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $338.31M derived: sum of 2 quarters · filed 2026-02-26 | $518.20M derived: sum of 3 quarters · filed 2026-07-29 | $699.70M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $169.05M 10-Q · filed 2025-10-30 | $348.94M derived: sum of 2 quarters · filed 2026-07-29 | $530.43M 10-Q · filed 2025-10-30 | $708.95M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $179.89M 10-Q · filed 2026-07-29 | $361.39M 10-Q · filed 2026-07-29 | $539.91M derived: sum of 3 quarters · filed 2026-07-29 | $717.10M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $181.50M 10-Q · filed 2026-05-05 | $360.02M derived: sum of 2 quarters · filed 2026-05-05 | $537.21M derived: sum of 3 quarters · filed 2026-05-05 | $732.68M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $178.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $355.71M derived: sum of 2 quarters · filed 2026-02-26 | $551.18M derived: sum of 3 quarters · filed 2026-02-26 | $716.98M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $177.19M 10-Q · filed 2025-10-30 | $372.67M derived: sum of 2 quarters · filed 2025-10-30 | $538.46M 10-Q · filed 2025-10-30 | $701.59M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $195.47M 10-Q · filed 2025-07-31 | $361.27M 10-Q · filed 2025-07-31 | $524.40M derived: sum of 3 quarters · filed 2026-02-26 | $686.35M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $165.80M 10-Q · filed 2025-05-05 | $328.93M derived: sum of 2 quarters · filed 2026-02-26 | $490.87M derived: sum of 3 quarters · filed 2026-02-26 | $655.78M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $163.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $325.08M derived: sum of 2 quarters · filed 2026-02-26 | $489.98M derived: sum of 3 quarters · filed 2026-02-26 | $656.64M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $161.95M 10-Q · filed 2024-11-04 | $326.86M derived: sum of 2 quarters · filed 2024-11-04 | $493.51M 10-Q · filed 2024-11-04 | $645.43M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $164.91M 10-Q · filed 2024-07-29 | $331.56M 10-Q · filed 2024-07-29 | $483.48M derived: sum of 3 quarters · filed 2025-02-25 | $627.30M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $166.66M 10-Q · filed 2024-05-06 | $318.58M derived: sum of 2 quarters · filed 2025-02-25 | $462.40M derived: sum of 3 quarters · filed 2025-02-25 | $623.05M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $151.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $295.74M derived: sum of 2 quarters · filed 2025-02-25 | $456.39M derived: sum of 3 quarters · filed 2025-02-25 | $616.32M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $143.82M 10-Q · filed 2023-10-25 | $304.47M derived: sum of 2 quarters · filed 2023-10-25 | $464.40M 10-Q · filed 2023-10-25 | $626.65M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $160.65M 10-Q · filed 2023-07-27 | $320.58M 10-Q · filed 2023-07-27 | $482.83M derived: sum of 3 quarters · filed 2024-02-28 | $638.84M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $159.93M 10-Q · filed 2023-04-26 | $322.18M derived: sum of 2 quarters · filed 2024-02-28 | $478.19M derived: sum of 3 quarters · filed 2024-02-28 | $640.74M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $162.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $318.26M derived: sum of 2 quarters · filed 2024-02-28 | $480.81M derived: sum of 3 quarters · filed 2024-02-28 | $637.45M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $156.01M 10-Q · filed 2022-10-26 | $318.56M derived: sum of 2 quarters · filed 2022-10-26 | $475.19M 10-Q · filed 2022-10-26 | $637.59M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $162.55M 10-Q · filed 2022-07-27 | $319.19M 10-Q · filed 2022-07-27 | $481.57M derived: sum of 3 quarters · filed 2023-02-22 | $631.65M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $156.63M 10-Q · filed 2022-04-27 | $319.02M derived: sum of 2 quarters · filed 2023-02-22 | $469.10M derived: sum of 3 quarters · filed 2023-02-22 | $585.21M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $162.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $312.47M derived: sum of 2 quarters · filed 2023-02-22 | $428.57M derived: sum of 3 quarters · filed 2023-02-22 | $594.53M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $150.08M 10-Q · filed 2021-11-02 | $266.18M derived: sum of 2 quarters · filed 2021-11-02 | $432.14M 10-Q · filed 2021-11-02 | $606.39M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $116.11M 10-Q · filed 2021-07-29 | $282.06M 10-Q · filed 2021-07-29 | $456.31M derived: sum of 3 quarters · filed 2022-02-24 | $629.41M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $165.95M 10-Q · filed 2021-04-29 | $340.21M derived: sum of 2 quarters · filed 2022-02-24 | $513.30M derived: sum of 3 quarters · filed 2022-02-24 | $678.68M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $174.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $347.35M derived: sum of 2 quarters · filed 2022-02-24 | $512.73M derived: sum of 3 quarters · filed 2022-02-24 | $687.60M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $173.10M 10-Q · filed 2020-10-29 | $338.48M derived: sum of 2 quarters · filed 2020-10-29 | $513.35M 10-Q · filed 2020-10-29 | $690.57M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $165.38M 10-Q · filed 2020-08-10 | $340.25M 10-Q · filed 2020-08-10 | $517.48M derived: sum of 3 quarters · filed 2021-02-23 | $690.83M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $174.87M 10-Q · filed 2020-05-07 | $352.10M derived: sum of 2 quarters · filed 2021-02-23 | $525.45M derived: sum of 3 quarters · filed 2021-02-23 | $702.05M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $177.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $350.58M derived: sum of 2 quarters · filed 2021-02-23 | $527.18M derived: sum of 3 quarters · filed 2021-02-23 | $690.75M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $173.35M 10-Q · filed 2019-10-25 | $349.95M derived: sum of 2 quarters · filed 2019-10-25 | $513.52M 10-Q · filed 2019-10-25 | $704.16M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $176.60M 10-Q · filed 2019-07-25 | $340.16M 10-Q · filed 2019-07-25 | $530.80M derived: sum of 3 quarters · filed 2020-02-21 | $676.75M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $163.57M 10-Q · filed 2019-04-29 | $354.20M derived: sum of 2 quarters · filed 2020-02-21 | $500.15M derived: sum of 3 quarters · filed 2020-02-21 | $645.16M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $190.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $336.58M derived: sum of 2 quarters · filed 2020-02-21 | $481.60M derived: sum of 3 quarters · filed 2020-02-21 | $624.10M 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | $145.94M 10-Q · filed 2018-11-01 | $290.96M derived: sum of 2 quarters · filed 2018-11-01 | $433.46M 10-Q · filed 2018-11-01 | $545.58M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $145.01M 10-Q · filed 2018-07-26 | $287.51M 10-Q · filed 2018-07-26 | $399.63M derived: sum of 3 quarters · filed 2019-02-26 | $511.95M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $142.50M 10-Q · filed 2018-04-26 | $254.62M derived: sum of 2 quarters · filed 2019-02-26 | $366.93M derived: sum of 3 quarters · filed 2019-02-26 | $486.15M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $112.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $224.44M derived: sum of 2 quarters · filed 2019-02-26 | $343.65M derived: sum of 3 quarters · filed 2019-02-26 | $455.63M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $112.32M 10-Q · filed 2017-10-26 | $231.53M derived: sum of 2 quarters · filed 2017-10-26 | $343.51M 10-Q · filed 2017-10-26 | $453.26M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $119.22M 10-Q · filed 2017-07-26 | $231.19M 10-Q · filed 2017-07-26 | $340.94M derived: sum of 3 quarters · filed 2018-03-01 | $454.37M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $111.97M 10-Q · filed 2017-04-26 | $111.96M 10-Q · filed 2016-04-27 | $221.72M derived: sum of 2 quarters · filed 2018-03-01 | $335.15M derived: sum of 3 quarters · filed 2018-03-01 | $434.47M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $109.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $223.17M derived: sum of 2 quarters · filed 2018-03-01 | $322.49M derived: sum of 3 quarters · filed 2018-03-01 | $415.76M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $113.42M 10-Q · filed 2016-10-28 | $212.74M derived: sum of 2 quarters · filed 2016-10-28 | $306.01M 10-Q · filed 2016-10-28 | $398.50M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $99.32M 10-Q · filed 2016-07-28 | $126.59M 10-Q · filed 2015-07-31 | $192.58M 10-Q · filed 2016-07-28 | $240.65M 10-Q · filed 2015-07-31 | $285.07M derived: sum of 3 quarters · filed 2017-02-23 | $378.86M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $93.27M 10-Q · filed 2016-04-27 | $114.06M 10-Q · filed 2015-05-01 | $185.75M derived: sum of 2 quarters · filed 2017-02-23 | $279.54M derived: sum of 3 quarters · filed 2017-02-23 | $394.79M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $92.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $186.28M derived: sum of 2 quarters · filed 2017-02-23 | $301.53M derived: sum of 3 quarters · filed 2017-02-23 | $375.55M 10-K · filed 2017-02-23 | $445.97M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $93.79M 10-Q · filed 2015-11-04 | $109.90M 10-Q · filed 2014-11-07 | $209.04M derived: sum of 2 quarters · filed 2015-11-04 | $283.06M 10-Q · filed 2015-11-04 | $333.49M 10-Q · filed 2014-11-07 | $343.53M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-06-30 | $115.25M 10-Q · filed 2015-07-31 | $223.59M 10-Q · filed 2015-07-31 | $249.74M derived: sum of 3 quarters · filed 2016-02-26 | $349.54M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $108.34M 10-Q · filed 2015-05-01 | $134.49M derived: sum of 2 quarters · filed 2016-02-26 | $234.28M derived: sum of 3 quarters · filed 2016-02-26 | $337.56M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $26.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $125.95M derived: sum of 2 quarters · filed 2016-02-26 | $229.23M derived: sum of 3 quarters · filed 2016-02-26 | $332.19M 10-K · filed 2016-02-26 | $394.25M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | $99.79M 10-Q · filed 2014-11-07 | $95.93M 10-Q · filed 2013-10-30 | $203.07M derived: sum of 2 quarters · filed 2014-11-07 | $306.04M 10-Q · filed 2014-11-07 | $295.71M 10-Q · filed 2013-10-30 | $402.57M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $103.28M 10-Q · filed 2014-08-05 | $99.62M 10-Q · filed 2013-08-01 | $206.24M 10-Q · filed 2014-08-05 | $199.78M 10-Q · filed 2013-08-01 | $302.77M derived: sum of 3 quarters · filed 2015-02-27 | $395.85M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $102.96M 10-Q · filed 2014-05-01 | $100.16M 10-Q · filed 2013-05-02 | $199.49M derived: sum of 2 quarters · filed 2015-02-27 | $292.57M derived: sum of 3 quarters · filed 2015-02-27 | $388.67M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $96.53M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $189.61M derived: sum of 2 quarters · filed 2015-02-27 | $285.70M derived: sum of 3 quarters · filed 2015-02-27 | $373.11M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $93.08M 10-Q · filed 2013-10-30 | $189.17M derived: sum of 2 quarters · filed 2013-10-30 | $276.58M 10-Q · filed 2013-10-30 | $371.39M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-06-30 | $96.10M 10-Q/A · filed 2013-08-02 | $183.51M 10-Q/A · filed 2013-08-02 | $278.32M derived: sum of 3 quarters · filed 2014-06-20 | $365.82M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-03-31 | $87.41M 10-Q · filed 2013-05-02 | $182.22M derived: sum of 2 quarters · filed 2014-06-20 | $269.73M derived: sum of 3 quarters · filed 2014-06-20 | $365.46M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2011-12-31 | $94.81M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $182.32M derived: sum of 2 quarters · filed 2014-06-20 | $278.05M derived: sum of 3 quarters · filed 2014-06-20 | $358.13M 8-K · filed 2014-06-20 | ||||
| 2011-09-30 | $87.51M 10-Q · filed 2012-10-24 | $183.24M derived: sum of 2 quarters · filed 2012-10-24 | $263.32M 10-Q · filed 2012-10-24 | $345.91M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $95.73M 10-Q · filed 2012-07-31 | $175.82M 10-Q · filed 2012-07-31 | $258.41M derived: sum of 3 quarters · filed 2013-02-26 | $334.14M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $80.08M 10-Q · filed 2012-04-26 | $162.67M derived: sum of 2 quarters · filed 2013-02-26 | $238.41M derived: sum of 3 quarters · filed 2013-02-26 | $312.63M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $82.59M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $158.33M derived: sum of 2 quarters · filed 2013-02-26 | $232.54M derived: sum of 3 quarters · filed 2013-02-26 | $305.06M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $75.74M 10-Q · filed 2011-10-31 | $149.95M derived: sum of 2 quarters · filed 2011-10-31 | $222.47M 10-Q · filed 2011-10-31 | $298.95M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $74.22M 10-Q · filed 2011-08-01 | $146.73M 10-Q · filed 2011-08-01 | $223.21M derived: sum of 3 quarters · filed 2012-02-27 | $293.13M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $72.51M 10-Q · filed 2011-04-28 | $149.00M derived: sum of 2 quarters · filed 2012-02-27 | $218.91M derived: sum of 3 quarters · filed 2012-02-27 | $287.16M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $76.48M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $146.40M derived: sum of 2 quarters · filed 2012-02-27 | $214.65M derived: sum of 3 quarters · filed 2012-02-27 | $281.10M 10-K · filed 2012-02-27 | ||||
| 2009-09-30 | $69.92M 10-Q · filed 2010-10-28 | $138.17M derived: sum of 2 quarters · filed 2010-10-28 | $204.62M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $68.25M 10-Q · filed 2010-07-29 | $134.70M 10-Q · filed 2010-07-29 | ||||||
| 2008-12-31 | $281.00M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |